Louis-Brennetot, C., Delattre, O., & Janoueix-Lerosey, I. (2020). High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma. EBioMedicine.
Chicago Stili AlıntıLouis-Brennetot, Caroline, Olivier Delattre, ve Isabelle Janoueix-Lerosey. "High CD44 Expression Is Not a Prognosis Marker in Patients With High-risk Neuroblastoma." EBioMedicine 2020.
MLA AlıntıLouis-Brennetot, Caroline, Olivier Delattre, ve Isabelle Janoueix-Lerosey. "High CD44 Expression Is Not a Prognosis Marker in Patients With High-risk Neuroblastoma." EBioMedicine 2020.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..